testing guidelines

Research in Review

Mutations in CLL Cells May Be Used as Biomarker for Future Relapse

05/09/2017

JCP Editors

Certain mutations in relapsed chronic lymphocytic leukemia (CLL) after targeted therapy have the potential to be used as a biomarker for relapse, according to research published in the Journal of Clinical Oncology...

...

05/09/2017

Journal of Clinical Pathways

Research in Review

New Biomarker Helps Predict PFS in Patients With Type of NSCLC

05/05/2017

JCP Editors

Patients with ALK-rearranged non-small cell lung cancer (NSCLC) who are treated with crizotinib may experience increased progression-free survival (PFS) with a decrease in a type of circulating tumor cells, according...

...

05/05/2017

Journal of Clinical Pathways

Research in Review

MRI Results After DCIS Biopsy Unreliable, Leads to Overtreatment

05/04/2017

JCP Editors

MRI results after percutaneous biopsy for ductal carcinoma in situ (DCIS) often overestimate the extent of breast cancer, resulting in unnecessary mastectomies, according to a presentation at the American Society of...

MRI...

05/04/2017

Journal of Clinical Pathways

Inappropriate Thrombophilia Testing Remains High Among Hospital Inpatients

11/30/2016

JCP Editors

Inappropriate or unnecessary thrombophilia testing remains a frequent problem in the hospital inpatient setting, leading to significant financial ramifications and the potential for adverse medical care, according to...

...

11/30/2016

Journal of Clinical Pathways

Research in Review

Blood Test Helps Predict Treatment Response for Patients With SCLC

11/29/2016

JCP Editors

Patterns of gene copy number aberrations (CNAs) in isolated small-cell lung cancer (SCLC) cells may help determine how patients will respond to chemotherapy, according to a study published...

...

11/29/2016

Journal of Clinical Pathways